On the other hand, patients of non-malignant diseases and healthy persons, as a control group, were also surveyed randomly on the same items during the same period.
In this survey, foreigners, atomic-bomb survivors, and persons occupationally exposed to radiations, such as radiologists, x-ray technicians and nurses, were excluded from statistical consideration. 5-7
RESULTS

1) Leukemia group
During the survey period of 5 years, 1,932 cards of leukemic patients were collected as is shown in Table 1 . Of them, 618 cards were of malignant lymphomas and 117 cards unavailable on account of unknown sex or age, foreigners, atomic-bomb survivors, etc., as presented in Tables 2 and 3 . Therefore, these were excluded from the statistical considerations. Thus, 1,197 available cards were prepared for survey. Classification of leukemic patients according to Table 4 .$ Out of 1,197 leukemic patients, 49 or 4.09 per cent had a history of fluoroscopic examination, and 19 or 1.59 per cent had a history of radiation therapy more than one year prior to the onset of leukemia. Further, of 395 children under the age of 15 years, 7 or 1.95 per cent had been subjected to intrauterine exposure to medical radiations including radiography. The age and sex distributions of subjects exposed to medical radiations are shown in Table 5 .
2) Control group
Controls were surveyed at the same time. Similar questionnaires were sent to the same hospitals as those requested to survey leukemic patients. Controls consisted of patients with non-malignant diseases or healthy persons, who were chosen randomly. Since we did not use the method of the matched sampling,s,10 we practically decided sample numbers of controls as follows: First, all controls were chosen from available cards in 1962. Secondly, a total of 1,950 available cards of controls obtained in 1964 were classified according to sex and age. Of each sex and age class, adequate numbers were sampled so that the total number of control subjects in 1962 and 1964 were twice as large as the number of leukemic patients collected until 1964, using the table of random numbers. Thirdly, in 1965, control subjects just three times larger in number than leukemic patients collected in the same year for each sex and age class were surveyed. Thus 2,609 available control subjects were chosen. The sex and age distributions in them are shown in Table 6 . The sampling numbers of each year are summarized in Table 7 .
The criterion of irradiation history in controls was as follows: In leukemic patients, irradiation history was surveyed in those who had received irradiations more than one year before the onset of disease .7,11 On the other hand, the average length of the period between the onset of disease and the date of survey was 9.61 months. Consequently, irradiation history checked in the leukemic group belonged in fact to a period more than one year and 9.61 months prior to the date of survey. Likewise, in the control group, it was checked that the subjects received irradiation more than one year and 9.61 months before the date of survey.
Thus, 146 of 2,609 controls or 5.60 per cent had a history of fluoroscopy and 13 or 0.50 per cent had a history of radiotherapy. Out of 765 control children under the age of 15 years, 12 or 1.57 per cent had a history of in utero exposure to radiation (Table 8 ). 
3) Statistical considerations
First, the question arose, which group had a larger irradiation ratio (the rate of persons who have irradiation history to the total sample number)? Fluoroscopic irradiation history was recorded in 4.09 per cent (49/1,197) in the leukemic group, and in 5.60 per cent (146/2,609) in the control group. The irradiation ratio was slightly higher in the control group than in the leukemic one without a statistically significant difference (x2=3.51, 0.05<p<0.10).
The therapeutic irradiation ratio was 1.59 per cent (19/1,197) in the leukemic group, and 0.50 per cent (13/2,609) in the control. The therapeutic irradiation ratio was higher in leukemic group than in the control, with a statistically significant difference (X2=10.4, 0.01>p). Namely, the rate of fluoroscopic examination, in which the subjects received radiations of relatively small doses, was about the same in the both grohps. However, the rate of radiotherapy, in which the sub jects received radiations of relatively large doses, was evidently higher in the leukemic group.
The second question is, which group received fluoroscopy more frequently? According to S. Koga (to be published), an average level of the skin dose of patients facing the x-ray tube was about 15 to 30R per fluoroscopy of the gastrointestinal tract. However, in the past, this level might have been fairly high, because of poor capacity of x-ray accessaries such as intensifying screen , x-ray film, etc.12 Therefore we assumed that, in a single fluoroscopic examina tion, the skin of patients facing the x-ray tube received radiation doses of 20 to 40 R at least. The both groups were classified according to the frequency of fluoroscopy, as summarized in Table 9 . The average frequency of fluoroscopy in the past was 0.21 times per person in the leukemic patients , while it was 0.09 times in the controls. Therefore, it seems that the leukemic patients received fluoroscopy more frequently in the past as compared with controls. Although the Kolmogorov's test showed no significant difference in the two distribution types,13 there were more patients who had received fluoroscopy more than 3 times in the leukemic group. Actually 1.42 per cent (17/1,197) had fluoroscopic histories of more than 3 times in the leukemic group, and 0 .50 per cent (13/2,609) in the control one. The chi-square calculation revealed a statistically significant difference at the level of 1 per cent (x2=7.78). Namely, there were more patients who had received fluoroscopy in the past in the leukemic group than in the control one. The third question arises as to the radiation doses which were used . Previous irradiation conditions in the hospitals where the patients were treated should be referred to. However, most of them were not clear because the records had been lost on account of the Second World War. Therefore the radiation doses (air dose) were indirectly estimated by Kitabatake's method.9,14 Next, the bone marrow integral dose was calculated by means of Miyakawa and Hashizume's method.15-11 The classification of materials according to the bone marrow dose thus obtained is shown in Table 10 . That is, the average bone marrow dose received more than one year before the onset of disease was 2,704 TABLE 10. Comparison of bone marrow integral dose in leukemic and control groups grads in the leukemic group, and was 762 grads in control group. Since the average age of the both groups was 29.6 years, these corresponded to 91.4 grads/ year and 25.7 grads/year, respectively. Namely, the leukemic patients received radiations to the bone marrow in a dose of about 3.5 times as large as that in controls. Then, to check the presence of significant difference in bone marrow integral doses between the leukemic and control groups, we set where, ƒÊ1
is Therefore, t = 4.88 (t1% = 2.576) is obtained. Thus the null hypothesis is renounced, which indicates that bone marrow dose in leukemic patients is evidently larger than in controls.
The fourth question remains as to the intrauterine exposure ratio. In children under the age of 15 years, 1.95% (7/359) had a history of intrauterine exposure in leukemic patients, and 1.57% (12/765) in controls. The ratio was slightly higher in the leukemic group, but had no significant difference from that in the control group (x2=0.63, 0.05<p). Next, the ratio of acute to chronic leukemia (acute/chronic) was surveyed ,20 as shown in Table 11 . In the cases with a history of prior medical irradia tion (radiotherapy and more than three times of fluoroscopy) the ratio of acute/ chronic was 1.3, as compared with 1 .8 in all cases collected in this survey. Therefore there is no evidence to indicate that the incidence of acute leukemia increases after medical irradiation (local irradiation) . 4. The fluoroscopic irradiation ratio was slightly higher in control subjects than in the leukemic patients without a significant difference, while the therapeutic irradiation ratio was evidently higher in the leukemic patients than in controls with a significant difference at 1 per cent level.
5. The average frequency of fluoroscopy in the past was 0.21 times in the leukemic patients and 0.09 times in controls.
6. The average bone marrow integral dose was 2,704 grads in the leukemic patients, and 762 grads in controls. The leukemic patients had received larger bone marrow doses than the control subjects with a statistically significant difference at 1 per cent level. 7. From this survey it is concluded that medical irradiations such as radiotherapy or frequent fluoroscopy may be related closely with the incidence of leu kemia in the human being.
